1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Schweimer, K.
Hoffmann, S.
Friedrich, U.
Biesinger, B.
Roesch, P.
Sticht, H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
41
5120
10.1021/BI015986J
11955060
Structural Investigation of the Binding of a Herpesviral Protein to the SH3 Domain of Tyrosine Kinase Lck
2002
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7008.682
PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK
SH3 DOMAIN RESIDUES 57-119
1
man
polymer
TYROSINE-PROTEIN KINASE LCK, P56-LCK
no
no
GSPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKAN
GSPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKAN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
INTRACELLULAR
9606
HOMO SAPIENS
511693
ESCHERICHIA COLI
BL21
PGEX-4T-2
repository
Initial release
Version format compliance
Version format compliance
1
0
2001-10-22
1
1
2011-05-07
1
2
2011-07-13
STRUCTURE-BASED DESIGN OF A NOVEL, OSTEOCLAST-SELECTIVE,NONPEPTIDE SRC SH2 INHIBITOR WITH IN VIVO ANTI-RESORPTIVEACTIVITY
SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56- LCK TYROSINE KINASE COMPLEXED WITH THE 11 RESIDUE PHOSPHOTYROSYL PEPTIDE EPQPYEEIPIYL
SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 10 RESIDUE SYNTHETIC PHOSPHOTYROSYL PEPTIDE TEGQPYQPQPA
STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE.
THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
PDBE
Y
PDBE
2001-02-22
REL
THE ALA TO GLY MUTATION AROSE FROM THE EXPRESSION SYSTEM
USED IN WHICH THE N-TERMINAL GST-FUSION PARTNER WAS
REMOVED BY THROMBIN CLEAVAGE.
THE STRUCTURE WAS DETERMINED USING TRIPLE RESONANCE NMR SPECTROSCOPY ON 13C, 15N LABELED LCK-SH3 DOMAIN
LEAST RESTRAINT VIOLATION
100
30
3D 15N-EDITED NOESY
3D 13C-EDITED NOESY
2D 15N-FILTERED NOESY
150
mM
6.4
pH
1
atm
298
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
AB INITIO SIMULATED ANNEALING
1
BRUNGER
refinement
X-PLOR
3.851
structure solution
NMRVIEW
structure solution
XPLOR
600
Bruker
DRX
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
PRO
3
n
3
PRO
3
A
LEU
4
n
4
LEU
4
A
GLN
5
n
5
GLN
5
A
ASP
6
n
6
ASP
6
A
ASN
7
n
7
ASN
7
A
LEU
8
n
8
LEU
8
A
VAL
9
n
9
VAL
9
A
ILE
10
n
10
ILE
10
A
ALA
11
n
11
ALA
11
A
LEU
12
n
12
LEU
12
A
HIS
13
n
13
HIS
13
A
SER
14
n
14
SER
14
A
TYR
15
n
15
TYR
15
A
GLU
16
n
16
GLU
16
A
PRO
17
n
17
PRO
17
A
SER
18
n
18
SER
18
A
HIS
19
n
19
HIS
19
A
ASP
20
n
20
ASP
20
A
GLY
21
n
21
GLY
21
A
ASP
22
n
22
ASP
22
A
LEU
23
n
23
LEU
23
A
GLY
24
n
24
GLY
24
A
PHE
25
n
25
PHE
25
A
GLU
26
n
26
GLU
26
A
LYS
27
n
27
LYS
27
A
GLY
28
n
28
GLY
28
A
GLU
29
n
29
GLU
29
A
GLN
30
n
30
GLN
30
A
LEU
31
n
31
LEU
31
A
ARG
32
n
32
ARG
32
A
ILE
33
n
33
ILE
33
A
LEU
34
n
34
LEU
34
A
GLU
35
n
35
GLU
35
A
GLN
36
n
36
GLN
36
A
SER
37
n
37
SER
37
A
GLY
38
n
38
GLY
38
A
GLU
39
n
39
GLU
39
A
TRP
40
n
40
TRP
40
A
TRP
41
n
41
TRP
41
A
LYS
42
n
42
LYS
42
A
ALA
43
n
43
ALA
43
A
GLN
44
n
44
GLN
44
A
SER
45
n
45
SER
45
A
LEU
46
n
46
LEU
46
A
THR
47
n
47
THR
47
A
THR
48
n
48
THR
48
A
GLY
49
n
49
GLY
49
A
GLN
50
n
50
GLN
50
A
GLU
51
n
51
GLU
51
A
GLY
52
n
52
GLY
52
A
PHE
53
n
53
PHE
53
A
ILE
54
n
54
ILE
54
A
PRO
55
n
55
PRO
55
A
PHE
56
n
56
PHE
56
A
ASN
57
n
57
ASN
57
A
PHE
58
n
58
PHE
58
A
VAL
59
n
59
VAL
59
A
ALA
60
n
60
ALA
60
A
LYS
61
n
61
LYS
61
A
ALA
62
n
62
ALA
62
A
ASN
63
n
63
ASN
63
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
54
A
N
ILE
54
A
O
TRP
41
A
O
TRP
41
A
N
GLN
44
A
N
GLN
44
A
O
ARG
32
A
O
ARG
32
A
N
LEU
31
A
N
LEU
31
A
O
VAL
9
A
O
VAL
9
A
N
ILE
10
A
N
ILE
10
A
O
ALA
60
A
O
ALA
60
1
A
A
O
H
ALA
GLY
11
28
1.56
1
A
A
H
O
LEU
PHE
12
58
1.57
2
A
A
O
H
ALA
GLY
11
28
1.54
2
A
A
H
O
LEU
PHE
12
58
1.58
2
A
A
H
O
LEU
LYS
34
42
1.59
3
A
A
O
H
ALA
GLY
11
28
1.52
3
A
A
H
O
ARG
GLN
32
44
1.58
3
A
A
H
O
LEU
PHE
12
58
1.58
3
A
A
O
H
TRP
ILE
41
54
1.58
4
A
A
H
O
LEU
PHE
12
58
1.55
4
A
A
O
H
ALA
GLY
11
28
1.56
5
A
A
O
H
ALA
GLY
11
28
1.53
5
A
A
H
O
ARG
GLN
32
44
1.58
5
A
A
H
O
LEU
PHE
12
58
1.58
6
A
A
O
H
ALA
GLY
11
28
1.54
7
A
A
O
H
ALA
GLY
11
28
1.55
8
A
A
O
H
ALA
GLY
11
28
1.54
8
A
A
H
O
LEU
PHE
12
58
1.58
8
A
A
H
OE1
GLU
GLU
26
29
1.59
9
A
A
O
H
ALA
GLY
11
28
1.55
9
A
A
O
H
TRP
ILE
41
54
1.57
9
A
A
H
O
ARG
GLN
32
44
1.60
10
A
A
O
H
ALA
GLY
11
28
1.53
11
A
A
O
H
ALA
GLY
11
28
1.53
11
A
A
H
O
LEU
PHE
12
58
1.55
11
A
A
H
O
ARG
GLN
32
44
1.56
12
A
A
O
H
ALA
GLY
11
28
1.55
12
A
A
H
O
LEU
PHE
12
58
1.57
13
A
A
O
H
ALA
GLY
11
28
1.52
13
A
A
H
OE1
GLU
GLU
26
29
1.58
13
A
A
H
O
LEU
PHE
12
58
1.58
13
A
A
O
H
ARG
GLN
32
44
1.58
13
A
A
H
O
LEU
LYS
34
42
1.60
14
A
A
O
H
ALA
GLY
11
28
1.54
15
A
A
O
H
ALA
GLY
11
28
1.53
15
A
A
H
OE1
GLU
GLU
26
29
1.59
16
A
A
O
H
ALA
GLY
11
28
1.55
16
A
A
H
O
LEU
PHE
12
58
1.56
16
A
A
H
O
LEU
LYS
34
42
1.58
16
A
A
H
OE1
GLU
GLU
26
29
1.59
17
A
A
O
H
ALA
GLY
11
28
1.56
17
A
A
H
O
ARG
GLN
32
44
1.58
17
A
A
O
H
TRP
ILE
41
54
1.58
18
A
A
O
H
ALA
GLY
11
28
1.56
18
A
A
H
O
LEU
PHE
12
58
1.58
18
A
A
H
OE1
GLU
GLU
26
29
1.58
19
A
A
O
H
ALA
GLY
11
28
1.55
19
A
A
O
H
TRP
ILE
41
54
1.58
20
A
A
O
H
ALA
GLY
11
28
1.54
20
A
A
H
OE1
GLU
GLU
26
29
1.56
20
A
A
H
O
LEU
LYS
34
42
1.56
20
A
A
H
O
LEU
PHE
12
58
1.57
21
A
A
O
H
ALA
GLY
11
28
1.54
21
A
A
H
O
LEU
PHE
12
58
1.58
22
A
A
O
H
ALA
GLY
11
28
1.55
23
A
A
O
H
ALA
GLY
11
28
1.55
24
A
A
O
H
ALA
GLY
11
28
1.55
24
A
A
H
O
LEU
PHE
12
58
1.59
24
A
A
O
H
ASN
ILE
7
33
1.59
25
A
A
O
H
ALA
GLY
11
28
1.54
25
A
A
H
OE1
GLU
GLU
26
29
1.56
25
A
A
H
O
LEU
PHE
12
58
1.57
26
A
A
O
H
ALA
GLY
11
28
1.56
26
A
A
H
O
ARG
GLN
32
44
1.58
27
A
A
O
H
ALA
GLY
11
28
1.53
27
A
A
O
H
TRP
ILE
41
54
1.57
27
A
A
H
O
LEU
PHE
12
58
1.58
28
A
A
O
H
ALA
GLY
11
28
1.54
28
A
A
H
O
LEU
PHE
12
58
1.56
29
A
A
O
H
ALA
GLY
11
28
1.55
30
A
A
O
H
ALA
GLY
11
28
1.54
30
A
A
H
OE1
GLU
GLU
26
29
1.55
30
A
A
O
H
TRP
ILE
41
54
1.56
1
A
ARG
32
0.109
SIDE CHAIN
2
A
ARG
32
0.104
SIDE CHAIN
3
A
ARG
32
0.228
SIDE CHAIN
4
A
ARG
32
0.312
SIDE CHAIN
5
A
ARG
32
0.147
SIDE CHAIN
6
A
ARG
32
0.236
SIDE CHAIN
7
A
ARG
32
0.285
SIDE CHAIN
8
A
ARG
32
0.218
SIDE CHAIN
9
A
ARG
32
0.204
SIDE CHAIN
10
A
ARG
32
0.306
SIDE CHAIN
11
A
ARG
32
0.317
SIDE CHAIN
12
A
ARG
32
0.165
SIDE CHAIN
13
A
ARG
32
0.298
SIDE CHAIN
14
A
ARG
32
0.312
SIDE CHAIN
15
A
ARG
32
0.317
SIDE CHAIN
16
A
ARG
32
0.285
SIDE CHAIN
17
A
ARG
32
0.261
SIDE CHAIN
18
A
ARG
32
0.318
SIDE CHAIN
20
A
ARG
32
0.314
SIDE CHAIN
21
A
ARG
32
0.175
SIDE CHAIN
22
A
ARG
32
0.166
SIDE CHAIN
23
A
ARG
32
0.317
SIDE CHAIN
24
A
ARG
32
0.131
SIDE CHAIN
25
A
ARG
32
0.150
SIDE CHAIN
26
A
ARG
32
0.277
SIDE CHAIN
27
A
ARG
32
0.317
SIDE CHAIN
28
A
ARG
32
0.114
SIDE CHAIN
30
A
ARG
32
0.118
SIDE CHAIN
1
A
HIS
19
-128.23
-155.35
1
A
PHE
25
-45.57
171.11
2
A
PHE
25
-45.32
172.19
3
A
PHE
25
-48.46
172.50
4
A
PHE
25
-50.26
171.74
4
A
GLN
36
-142.09
58.60
4
A
PRO
55
-47.16
159.35
5
A
PHE
25
-44.78
169.59
6
A
PHE
25
-50.14
173.53
7
A
HIS
19
-141.02
-158.25
7
A
PHE
25
-49.91
171.21
8
A
PHE
25
-48.28
168.72
9
A
PRO
17
-59.96
91.53
9
A
PHE
25
-53.36
174.42
10
A
PHE
25
-48.74
175.78
11
A
HIS
13
-149.35
-158.95
11
A
PHE
25
-50.80
171.60
12
A
PHE
25
-47.36
171.88
13
A
PHE
25
-48.10
170.21
14
A
PHE
25
-50.43
174.44
15
A
GLU
16
-110.11
75.28
15
A
HIS
19
-140.55
-158.26
15
A
PHE
25
-54.20
172.71
16
A
PRO
17
-62.99
98.91
16
A
PHE
25
-52.94
171.35
16
A
GLU
35
-172.72
125.49
16
A
GLN
36
-101.87
62.88
17
A
LEU
4
55.86
-85.34
17
A
PHE
25
-50.76
176.33
18
A
PHE
25
-46.64
171.62
19
A
PHE
25
-49.29
174.55
19
A
ALA
62
-43.45
154.97
20
A
PHE
25
-45.31
171.13
20
A
GLN
36
-151.09
57.80
21
A
PHE
25
-53.39
176.57
22
A
GLU
16
-106.90
79.48
22
A
PRO
17
-47.45
109.62
22
A
PHE
25
-54.76
175.99
23
A
PRO
17
-48.55
104.55
23
A
PHE
25
-47.34
170.60
23
A
GLN
36
-142.25
58.10
23
A
PRO
55
-46.37
167.41
23
A
ALA
62
49.62
-145.73
24
A
PHE
25
-53.67
174.13
25
A
GLU
16
-114.07
73.87
25
A
PHE
25
-47.07
169.45
25
A
ALA
60
-160.26
-41.28
25
A
ALA
62
49.18
25.13
26
A
HIS
19
-129.13
-159.34
26
A
PHE
25
-48.43
173.43
27
A
PHE
25
-53.12
173.73
28
A
PHE
25
-52.61
175.44
29
A
GLU
16
-110.45
77.83
29
A
PRO
17
-41.52
98.99
29
A
PHE
25
-54.13
174.50
30
A
PRO
17
-44.36
96.20
30
A
PHE
25
-48.71
172.35
PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK
SH3 domain of human Lck tyrosine kinase
1
N
N
TRANSFERASE
TRANSFERASE, SH3 DOMAIN, TYROSINE KINASE, SIGNAL TRANSDUCTION, LCK
LCK_HUMAN
UNP
1
P06239
57
119
1H92
1
63
P06239
A
1
1
63
1
ALA
conflict
GLY
1
1H92
A
P06239
UNP
57
1
5
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLU
51
A
GLU
51
A
PRO
55
A
PRO
55
A
TRP
40
A
TRP
40
A
SER
45
A
SER
45
A
GLN
30
A
GLN
30
A
ILE
33
A
ILE
33
A
LEU
8
A
LEU
8
A
ALA
11
A
ALA
11
A
VAL
59
A
VAL
59
A
LYS
61
A
LYS
61
1
P 1